GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (STU:45O) » Definitions » Cyclically Adjusted FCF per Share

Orgenesis (STU:45O) Cyclically Adjusted FCF per Share : €-1.29 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Orgenesis Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Orgenesis's adjusted free cash flow per share for the three months ended in Dec. 2023 was €-0.014. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-1.29 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -11.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -22.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Orgenesis was -11.50% per year. The lowest was -30.40% per year. And the median was -24.80% per year.

As of today (2024-04-27), Orgenesis's current stock price is €0.456. Orgenesis's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was €-1.29. Orgenesis's Cyclically Adjusted Price-to-FCF of today is .


Orgenesis Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Orgenesis's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Cyclically Adjusted FCF per Share Chart

Orgenesis Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.89 -0.95 -1.26 -1.29

Orgenesis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.26 -1.31 -1.35 -1.35 -1.29

Competitive Comparison of Orgenesis's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Orgenesis's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orgenesis's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orgenesis's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Orgenesis's Cyclically Adjusted Price-to-FCF falls into.



Orgenesis Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Orgenesis's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.014/129.4194*129.4194
=-0.014

Current CPI (Dec. 2023) = 129.4194.

Orgenesis Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201402 -0.084 99.057 -0.110
201405 -0.068 100.373 -0.088
201408 -0.029 100.352 -0.037
201411 -0.055 99.635 -0.071
201502 -0.122 99.032 -0.159
201505 -0.105 100.333 -0.135
201508 -0.245 100.548 -0.315
201511 -0.229 100.135 -0.296
201602 -0.178 100.040 -0.230
201605 -0.116 101.355 -0.148
201608 -0.130 101.617 -0.166
201611 -0.132 101.829 -0.168
201702 0.015 102.779 0.019
201705 -0.226 103.256 -0.283
201708 -0.149 103.587 -0.186
201711 -0.060 104.072 -0.075
201802 -0.199 105.052 -0.245
201805 -0.444 106.148 -0.541
201808 -0.444 106.383 -0.540
201811 -0.251 106.338 -0.305
201903 -0.315 107.251 -0.380
201906 -0.300 108.070 -0.359
201909 -0.321 108.329 -0.383
201912 -0.488 108.420 -0.583
202003 -0.733 108.902 -0.871
202006 -0.389 108.767 -0.463
202009 -0.396 109.815 -0.467
202012 -1.565 109.897 -1.843
202103 -0.176 111.754 -0.204
202106 -0.426 114.631 -0.481
202109 -0.356 115.734 -0.398
202112 -0.254 117.630 -0.279
202203 -0.136 121.301 -0.145
202206 -0.376 125.017 -0.389
202209 -0.301 125.227 -0.311
202212 -0.599 125.222 -0.619
202303 -0.301 127.348 -0.306
202306 -0.209 128.729 -0.210
202309 -0.048 129.860 -0.048
202312 -0.014 129.419 -0.014

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Orgenesis  (STU:45O) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Orgenesis Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Orgenesis's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Orgenesis (STU:45O) Business Description

Industry
Traded in Other Exchanges
Address
20271 Goldenrod Lane, Germantown, MD, USA, 20876
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Morgenesis and Therapies.

Orgenesis (STU:45O) Headlines

No Headlines